SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-027401
Filing Date
2013-05-09
Accepted
2013-05-09 16:02:27
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v342466_10q.htm 10-Q 585056
2 EXHIBIT 31.1 v342466_ex31-1.htm EX-31.1 11301
3 EXHIBIT 32.1 v342466_ex32-1.htm EX-32.1 4216
  Complete submission text file 0001144204-13-027401.txt   5355417

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lixt-20130331.xml EX-101.INS 680781
5 XBRL TAXONOMY EXTENSION SCHEMA lixt-20130331.xsd EX-101.SCH 73589
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lixt-20130331_cal.xml EX-101.CAL 29208
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lixt-20130331_def.xml EX-101.DEF 229135
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lixt-20130331_lab.xml EX-101.LAB 409376
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lixt-20130331_pre.xml EX-101.PRE 275345
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 13828584
SIC: 2834 Pharmaceutical Preparations